Pharmaceuticals Market Research Reports & Industry Analysis

Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.

The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.

The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.

Found 15369 publications
Global Combined Hormonal Contraceptives (CHC) Market: Trends and Opportunities (2014-19) US$ 800.00

Scope of the Report The report titled “Global Combined Hormonal Contraceptive (CHC) Market: Trends and Opportunities (2014-2019)” provides an in-depth analysis of ... that are and will be driving growth of the industry. Growth of the overall CHC industry has also been forecasted for the period 2014-19, taking ...

Jan, 2015 64 pages
Research and Investment Prospect of Human Vaccine Industry in China, 2014-2018 US$ 2,000.00

Research and Investment Prospect of Human Vaccine Industry in China, 2014-2018, mainly studies the market, competition pattern and segmentations of human ... of state-owned enterprises, private enterprises and foreign-funded enterprises in China. Seeing from the lot release quantity of vaccine in 2013, the state ...

Dec, 2014 56 pages
2015 Global Therapeutic Drug Monitoring Market: US, Europe, Japan Test Volume and Sales Forecasts by Country and Market Segment US$ 7,500.00

... a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others."Therapeutic Dry Monitoring: US, Europe, Japan" is a unique worldwide market and technology assessment designed to help current suppliers and potential market entrants ...

Jan, 2015 306 pages
2015 Global Nucleic Acid Testing and DNA Sequencing Market: Facilities, Test Volumes, and Sales Forecasts by Country (DataPack) US$ 1,500.00

This report provides: Estimates of facilities performing DNA sequencing and molecular diagnostic testing in France, Germany, Italy, Japan, Spain, UK and USA. Five-year test volume and sales forecasts by country.

Jan, 2015
2015 Global Nucleic Acid Testing (NAT) Market: Sales Forecasts by Country and Strategic Profiles of Leading Suppliers US$ 3,500.00

... , as well as test volume and sales forecasts by country. The report also presents strategic profiles of current and emerging suppliers of nucleic acid testing products in terms of their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and ...

Jan, 2015 109 pages
2015 Global Drugs of Abuse Testing Market: US, Europe, Japan Test Volume and Sales Forecasts by Country and Market Segment US$ 7,500.00

... for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others."Drugs of Abuse Testing Market: US, Europe, Japan" is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging ...

Jan, 2015 311 pages
2015 Analysis of Nucleic Acid Testing Instrumentation, and Strategic Profiles of Leading Suppliers US$ 3,500.00

... is already available on the market, e.g., DNA extractors, DNA synthesizers, thermal cyclers, robotic work-stations, and automated DNA probe analysis systems. The report reviews current instrumentation technologies, and compares features of leading molecular diagnostics analyzers marketed by Abbott, Beckman ...

Jan, 2015 103 pages
2015 Analysis of Nucleic Acid Diagnostic Technologies, and Strategic Profiles of Leading Suppliers US$ 3,500.00

... , biochips, genosensors, microarrays, labs-on-the-chip, and other.The report also presents strategic assessments of current and emerging suppliers of nucleic acid testing products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative ...

Jan, 2015 180 pages
2015 Analysis of Emerging Nucleic Acid Testing Assays, and Strategic Profiles of Leading Suppliers US$ 3,500.00

... clinical significance and market needs for major current and emerging NAT assays, as well as extensive listings of companies developing and marketing ... . This report also presents strategic assessments of current and emerging suppliers of nucleic acid testing products, including their sales, product portfolios ...

Jan, 2015 549 pages
Intramuscular Drug Delivery Market & Pipeline Insight US$ 2,400.00

... The higher sales will depend upon efficacy of newly developed intramuscular drug and marketing strategy to drive its sales. They are used ... supposed to be cost effective along with pharmacologically efficient and minimized side effects. “Intramuscular Drug Delivery Market & Pipeline Insight” Report Findings: ...

Jan, 2015 900 pages
US Pharmacy Benefit Management (PBM) Industry Report: 2014 Edition US$ 800.00

In the US, Pharmacy Benefit Management (PBM) deals with the management of prescription drug programs. It acts as an intermediary between health plans, drug companies, ... companies having a vicious competition with each other and dominating the PBM industry are- Express Script, CVS Health and Catamaran. These ...

Jan, 2015 50 pages
2015 Market Research Report on Global Pharmaceutical Plastic Bottles Industry US$ 2,600.00

... information is listed as products, customers, application, capacity, market position, and company contact information, etc. 2015-2020 forecast on capacity, production, cost, price, profit, production value, and gross margin for these markets are also included. For technical data and manufacturing plants ...

Jan, 2015 144 pages
2015 Market Research Report on Global Pharmaceutical Glass Bottles Industry US$ 2,600.00

... information is listed as products, customers, application, capacity, market position, and company contact information, etc. 2015-2020 forecast on capacity, production, cost, price, profit, production value, and gross margin for these markets are also included. For technical data and manufacturing plants ...

Jan, 2015 157 pages
China poultry vaccine Industry, 2015 US$ 3,600.00

... partner with one of the key Chinese corporations, to get market shares as China is boosting its domestic needs; to forecast the future of the world economy ... compete against any of the companies in this field, then China poultry vaccine industry, 2015 is required reading. This report will take 5 business days ...

Jan, 2015
China pharmaceutical Manufacturing Industry, 2015 US$ 3,600.00

... partner with one of the key Chinese corporations, to get market shares as China is boosting its domestic needs; to forecast the future of the world ... compete against any of the companies in this field, then China pharmaceutical manufacturing industry, 2015 is required reading. This report will take 5 business ...

Jan, 2015
China mouse nerve growth factor injection Industry, 2015 US$ 3,600.00

... to partner with one of the key Chinese corporations, to get market shares as China is boosting its domestic needs; to forecast the future of the world economy ... compete against any of the companies in this field, then China mouse nerve growth factor injection industry, 2015 is required reading. This report will ...

Jan, 2015
Small Molecule Cancer Drug Clinical Pipeline Insight US$ 2,400.00

... the treatment of Non-Small Cell Lung Cancer (NSCLC), Colon cancer, Breast and other cancers. Development of small molecule cancer drug generally ... Insight” Report Findings: Role of Small Molecule Drug in Cancer Treatment Mechanism of Small Molecule Cancer Drug Small Molecule Cancer Drugs Market Dynamics ...

Jan, 2015 1650 pages
Regenerative Medicine and Stem cell based Cell therapies-Drugs of the Future Offering Hope for Cure US$ 3,000.00

... Medicine and Stem cell based Cell therapies- Drugs of the Future Offering Hope for Cure'. This report describes the key ... Inc. 2. OCATA Therapeutics Inc. 3. Orgenesis 4. TiGenix NV 5. Pluristem Therapeutics Inc 6. Mesoblast Ltd 7. Medipost Co. Ltd 8. JCR Pharmaceuticals 9. Japan Tissue Engineering Co., Ltd

Jan, 2015 50 pages
Global Varicella Vaccine Industry 2014 Market Research Report US$ 2,850.00

2014 Global Varicella Vaccine Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Varicella Vaccine industry, focusing on the main regions (North America, Europe and Asia) and the main countries ( ...

Dec, 2014 176 pages
Global Pharmaceutical Glass Industry 2014 Market Research Report US$ 2,850.00

2014 Global Pharmaceutical Glass Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Pharmaceutical ... America, Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Pharmaceutical ...

Dec, 2014 176 pages
Global Hepatitis B Vaccine Industry 2014 Market Research Report US$ 2,850.00

2014 Global Hepatitis B Vaccine Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Hepatitis B Vaccine industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and ...

Dec, 2014 176 pages
Global Animal Vaccine Industry 2014 Market Research Report US$ 2,850.00

2014 Global Animal Vaccine Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Animal ... , Germany, Japan and China). The report firstly introduced the Animal Vaccine basics: definitions, classifications, applications and industry chain overview; ...

Dec, 2014 176 pages
Zanamivir - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) US$ 600.00

... , save searches and results This report covers: International Nonproprietary Name: Zanamivir indications: Treatment or prophylaxis of infections due to Influenza A or B viruses innovator: Glaxosmithkline (Relenza) Country Coverage: Australia Canada France Germany Great Britain Italy Japan ...

Jan, 2015
Vorapaxar - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) US$ 600.00

... This report covers: International Nonproprietary Name: Vorapaxar indications: Reduction of thrombotic cardiovascular events in patients with a history of myocardial infarction or with peripheral arterial disease innovator: Merck (Zontivity) Country Coverage: Australia Canada France Germany ...

Jan, 2015
Voglibose - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) US$ 600.00

... pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly ... Name: Voglibose indications: Lowering post-prandial blood glucose levels in people with diabetes mellitus innovator: Mascot Health (Voglib) Country Coverage ...

Jan, 2015
Vilanterol - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) US$ 600.00

... : Vilanterol indications: Maintenance bronchodilator treatment to relieve symptoms of chronic obstructive pulmonary disease, in combination with Umeclidinium bromide; Treatment of asthma in combination with Fluticasone furoate; Maintenance treatment of airflow obstruction and for reducing exacerbations in ...

Jan, 2015
Vemurafenib - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) US$ 600.00

... , save searches and results This report covers: International Nonproprietary Name: Vemurafenib indications: Treatment of BRAF V600 mutation-positive unresectable or metastatic melanoma innovator: Roche (Zelboraf) Country Coverage: Australia Canada France Germany Great Britain Italy Japan ...

Jan, 2015
Umeclidinium bromide, Vilanterol - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) US$ 600.00

... This report covers: International Nonproprietary Name: Umeclidinium bromide, Vilanterol indications: Maintenance bronchodilator treatment to relieve symptoms of chronic obstructive pulmonary disease innovator: GlaxoSmithKline (Anoro Ellipta, Laventair) Country Coverage: Australia Canada France ...

Jan, 2015
Umeclidinium bromide - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) US$ 600.00

... and results This report covers: International Nonproprietary Name: Umeclidinium bromide indications: Maintenance treatment to relieve symptoms of chronic obstructive pulmonary disease innovator: GlaxoSmithKline (Incruse, Incruse Ellipta) Country Coverage: Australia Canada France Germany Great ...

Jan, 2015
Tofacitinib - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) US$ 600.00

... and results This report covers: International Nonproprietary Name: Tofacitinib indications: Treatment of psoriasis; Treatment of rheumatoid arthritis optionally in combination with Methotrexate innovator: Pfizer (Xeljanz) Country Coverage: Australia Canada France Germany Great Britain Italy ...

Jan, 2015
Telithromycin - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) US$ 600.00

... spectrum of Telithromycin; Treatment of acute exacerbation of chronic bronchitis; Treatment of acute sinusitis; Treatment of tonsillitis or pharyngitis caused by streptococcus pyogenes, as an alternative when beta lactam antibiotics are not appropriate in countries/regions with a significant prevalence of ...

Jan, 2015
Telaprevir - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) US$ 600.00

... results This report covers: International Nonproprietary Name: Telaprevir indications: Treatment of chronic hepatitis C genotype 1 infection in combination with Peginterferon alfa and Ribavirin innovator: Vertex Pharm (Incivek); Janssen (Incivo) Country Coverage: Australia Canada France Germany ...

Jan, 2015
Teduglutide - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) US$ 600.00

... Add your own notes, save searches and results This report covers: International Nonproprietary Name: Teduglutide indications: Treatment of short bowel syndrome innovator: NPS Pharma (Revestive, Gattex) Country Coverage: Australia Canada France Germany Great Britain Italy Japan Spain USA ...

Jan, 2015
Tedizolid - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) US$ 600.00

... and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. “The most extensive source of ... Nonproprietary Name: Tedizolid indications: Treatment of acute bacterial skin and skin structure infections innovator: Cubist Pharm (Sivextro) Country Coverage: Australia ...

Jan, 2015
Tasimelteon - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) US$ 600.00

... own notes, save searches and results This report covers: International Nonproprietary Name: Tasimelteon indications: Treatment of non-24-hour sleep-wake disorder innovator: Vanda Pharm (Hetlioz) Country Coverage: Australia Canada France Germany Great Britain Italy Japan Spain USA Please ...

Jan, 2015
Tafluprost - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) US$ 600.00

... and results This report covers: International Nonproprietary Name: Tafluprost indications: Reduction of elevated intraocular pressure in open angle glaucoma and ocular hypertension, optionally as adjunctive therapy to beta blockers innovator: Santen (Taflotan, Tapros); Merck (Saflutan, Zioptan) ...

Jan, 2015
Ruxolitinib - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) US$ 600.00

... results This report covers: International Nonproprietary Name: Ruxolitinib indications: Treatment of intermediate or high-risk myelofibrosis (MF), including primary MF, post-polycythemia vera MF and post-essential thrombocythemia MF innovator: Incyte (Jakafi); Novartis (Jakavi) Country Coverage: ...

Jan, 2015
Rufinamide - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) US$ 600.00

... , save searches and results This report covers: International Nonproprietary Name: Rufinamide indications: Adjunctive treatment of seizures associated with Lennox-Gastaut syndrome innovator: Eisai (Banzel, Inovelon) Country Coverage: Australia Canada France Germany Great Britain Italy Japan ...

Jan, 2015
Roflumilast - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) US$ 600.00

... and results This report covers: International Nonproprietary Name: Roflumilast indications: Treatment and maintenance of severe chronic obstructive pulmonary disease, optionally in combination with bronchodilators and/or corticosteroids innovator: Nycomed (Daxas, Libertek); Merck (Daxas); Forest Res ( ...

Jan, 2015
Rilpivirine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) US$ 600.00

... results This report covers: International Nonproprietary Name: Rilpivirine indications: Treatment of HIV-1 in combination with Ritonavir and other antiretroviral agents innovator: Tibotec (Edurant); Gilead (Eviplera); Janssen (Edurant) Country Coverage: Australia Canada France Germany Great ...

Jan, 2015
Retigabine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) US$ 600.00

... , save searches and results This report covers: International Nonproprietary Name: Retigabine indications: Adjunctive treatment of partial onset seizures innovator: Glaxosmithkline (Trobalt); Valeant (Potiga) Country Coverage: Australia Canada France Germany Great Britain Italy Japan Spain ...

Jan, 2015
Repaglinide - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) US$ 600.00

... and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. “The most extensive source ... Name: Repaglinide indications: Treatment of type 2 diabetes mellitus innovator: Novo Nordisk (Prandin, NovoNorm, GlucoNorm, Prandimet); Daiichi Sankyo (Prandin) Country Coverage ...

Jan, 2015
Ranelic acid - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) US$ 600.00

... : International Nonproprietary Name: Ranelic acid indications: Treatment of postmenopausal osteoporosis to reduce the risk of fractures, optionally in combination with Vitamin D and/or Calcium innovator: Servier (Protos, Osseor, Protelos) Country Coverage: Australia Canada France Germany Great ...

Jan, 2015
Quetiapine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) US$ 600.00

... Nonproprietary Name: Quetiapine indications: Treatment of schizophrenia; Treatment of depressive episodes associated with bipolar disorder; Treatment or prevention of relapse/recurrence of manic, depressive or mixed episodes of bipolar disorder or of acute mania associated with bipolar disorder, as ...

Jan, 2015
Ponatinib - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) US$ 600.00

... Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. “The most extensive source of patent ... or blast phase chronic myeloid leukaemia or Philadelphia chromosome positive acute lymphoblastic leukaemia in patients with T315I mutation or no other tyrosine kinase therapy ...

Jan, 2015
Ospemifene - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) US$ 600.00

... your own notes, save searches and results This report covers: International Nonproprietary Name: Ospemifene indications: Treatment of moderate to severe dyspareunia innovator: Shionogi (Osphena) Country Coverage: Australia Canada France Germany Great Britain Italy Japan Spain USA Please ...

Jan, 2015
Ocriplasmin - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) US$ 600.00

... , save searches and results This report covers: International Nonproprietary Name: Ocriplasmin indications: Treatment of symptomatic vitreomacular adhesion innovator: ThromboGenics (Ocriplasmin); Alcon (Ocriplasmin) Country Coverage: Australia Canada France Germany Great Britain Italy Japan ...

Jan, 2015
Nelarabine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) US$ 600.00

... notes, save searches and results This report covers: International Nonproprietary Name: Nelarabine indications: Treatment of acute lymphoblastic leukaemia innovator: GlaxoSmithKline (Arranon, Atriance) Country Coverage: Australia Canada France Germany Great Britain Italy Japan Spain USA ...

Jan, 2015
Metformin, Vildagliptin - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) US$ 600.00

... This report covers: International Nonproprietary Name: Metformin, Vildagliptin indications: Treatment of type 2 diabetes mellitus, optionally in combination with a sulphonylurea or Insulin innovator: Novartis (Galvumet, Sobrea, Eucreas, Icandra, Zomarist) Country Coverage: Australia Canada France ...

Jan, 2015
Metformin, Sitagliptin - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) US$ 600.00

... and results This report covers: International Nonproprietary Name: Metformin, Sitagliptin indications: Improvement of glycemic control in patients with type 2 diabetes mellitus, optionally in combination with a PPARy agonist innovator: Merck (Janumet, Velmetia, Efficib, Ristfor) Country Coverage: ...

Jan, 2015
1 2 3 4 5 >
Skip to top